Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome

This study has been withdrawn prior to enrollment.
(The FDA IND application is paused due to additional required testing. The IRB protocol was closed prior to research starting.)
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00855972
First received: March 3, 2009
Last updated: December 14, 2010
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)